1. 1 Alhamdani, M. S., Al-Kassir, A. H., Abbas, F. K., Jaleel, N. A. and Al-Taee, M. F. (2007) Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells. Nephron Clin. Pract. 107; 26–34.
2. 2 Arai, H., Furusu, A., Nishino, T., Obata, Y., Nakazawa, Y., Nakazawa, M., Hirose, M., Abe, K., Koji, T. and Kohno, S. (2011) Thalidomide prevents the progression of peritoneal fibrosis in mice. Acta Histochem. Cytochem. 44; 51–60.
3. 3 Aroeira, L. S., Aguilera, A., Sánchez-Tomero, J. A., Bajo, M. A., del Peso, G., Jiménez-Heffernan, J. A., Selgas, R. and López-Cabrera, M. (2007) Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions. J. Am. Soc. Nephrol. 18; 2004–2013.
4. 4 Augustine, T., Brown, P. W., Davies, S. D., Summers, A. M. and Wilkie, M. E. (2009) Encapsulating peritoneal sclerosis: clinical significance and implications. Nephron Clin. Pract. 111; 149–154.
5. 5 Bertoli, S. V., Barone, M. T., Vago, L., Bonetto, S., De Vecchi, A., Scalamogna, A. and Barbiano di Belgiojoso, G. (1999) Changes in peritoneal membrane after continuous ambulatory peritoneal dialysis—a histopathological study. Adv. Perit. Dial. 15; 28–31.